Association of psychosocial factors with medication adherence in emerging adults with youth-onset type 2 diabetes: The iCount study
- PMID: 36220788
- DOI: 10.1111/pedi.13431
Association of psychosocial factors with medication adherence in emerging adults with youth-onset type 2 diabetes: The iCount study
Abstract
Aims: To assess associations of psychosocial factors with medication adherence in young adults with youth-onset type 2 diabetes in the Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY2) cohort.
Methods: Participants (mean age 26 years) completed validated psychosocial measures. Adherence to oral hypoglycemia agents (OHAs) was assessed with 3-monthly unannounced phone pill counts; insulin adherence by self-report. Logistic and linear regressions identified factors associated with "low-adherence" (<80% of pills/insulin) controlling for confounders.
Results: Of 212 participants taking OHAs (67% female, 39% Hispanic, 36% non-Hispanic Black), 69.8% were low-adherent. After adjustment, beliefs that medicines are necessary was associated with lower odds of low-adherence (p = 0.040, dichotomous). Less self-management support (p = 0.008), no healthcare coverage (p = 0.001), ≥1 (p = 0.008)/≥2 (p = 0.045) need insecurities were associated with higher odds of low-adherence. Factors associated with lower % adherence (continuous) were beliefs that medicines are harmful (p < 0.001)/overused (p = 0.007)/less necessary (p = 0.022), low self-management support (p = 0.003), food insecurity (p = 0.036), no healthcare coverage (p < 0.001), ≥1 (p = 0.003)/≥2 (p = 0.018) need insecurities. Of 192 taking insulin (69% female, 36% Hispanic, 41% non-Hispanic Black, 16% non-Hispanic white), 37.0% were low-adherent. Beliefs that medicines are overused (p = 0.009), that diabetes is not serious (p = 0.010), low diabetes self-efficacy (p = 0.035), high distress (p = 0.027), low self-management support (p = 0.001), food insecurity (p = 0.020), ≥1 (p = 0.011)/≥2 (p = 0.015) insecurities increased odds of insulin low-adherence.
Conclusions: Poor medication adherence, common in young adults with youth-onset type 2 diabetes, is associated with interfering beliefs, diabetes distress and social factors. We must address these factors to develop tailored interventions for this vulnerable group.
Keywords: medication adherence; psychology; social determinants of health; type 2 diabetes; young adults.
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Antihypertensive and Lipid-Lowering Medication Adherence in Young Adults With Youth-Onset Type 2 Diabetes.JAMA Netw Open. 2023 Oct 2;6(10):e2336964. doi: 10.1001/jamanetworkopen.2023.36964. JAMA Netw Open. 2023. PMID: 37792373 Free PMC article.
-
Psychosocial factors predict medication adherence in young adults with youth-onset type 2 diabetes: Longitudinal results from the TODAY2 iCount study.Diabet Med. 2023 May;40(5):e15062. doi: 10.1111/dme.15062. Epub 2023 Feb 17. Diabet Med. 2023. PMID: 36751994
-
Medication adherence in young adults with youth-onset type 2 diabetes: iCount, an observational study.Diabetes Res Clin Pract. 2022 Feb;184:109216. doi: 10.1016/j.diabres.2022.109216. Epub 2022 Jan 24. Diabetes Res Clin Pract. 2022. PMID: 35085644
-
Psychosocial aspects and contributions of behavioural science to medication-taking for adults with type 2 diabetes.Diabet Med. 2020 Mar;37(3):427-435. doi: 10.1111/dme.14214. Epub 2019 Dec 27. Diabet Med. 2020. PMID: 31837158 Review.
-
Factors associated with adherence or nonadherence to insulin therapy among adults with type 2 diabetes mellitus: A scoping review.J Diabetes Complications. 2023 Oct;37(10):108596. doi: 10.1016/j.jdiacomp.2023.108596. Epub 2023 Aug 22. J Diabetes Complications. 2023. PMID: 37651772
Cited by
-
Antihypertensive and Lipid-Lowering Medication Adherence in Young Adults With Youth-Onset Type 2 Diabetes.JAMA Netw Open. 2023 Oct 2;6(10):e2336964. doi: 10.1001/jamanetworkopen.2023.36964. JAMA Netw Open. 2023. PMID: 37792373 Free PMC article.
-
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations.Diabetes Metab Syndr Obes. 2023 Nov 16;16:3669-3689. doi: 10.2147/DMSO.S390752. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 38028995 Free PMC article. Review.
-
Psychosocial Factors and Glycemic Control in Young Adults With Youth-Onset Type 2 Diabetes.JAMA Netw Open. 2024 Apr 1;7(4):e245620. doi: 10.1001/jamanetworkopen.2024.5620. JAMA Netw Open. 2024. PMID: 38587841 Free PMC article.
-
Psychosocial predictors of diabetes self-efficacy in young adults with youth-onset type 2 diabetes.J Behav Med. 2025 Jun;48(3):500-512. doi: 10.1007/s10865-025-00554-1. Epub 2025 Mar 5. J Behav Med. 2025. PMID: 40042753
-
Life Lessons and Diabetes Research.Diabetes Spectr. 2024 Oct 22;38(1):108-114. doi: 10.2337/ds24-0065. eCollection 2025 Winter. Diabetes Spectr. 2024. PMID: 39959523
References
REFERENCES
-
- Tamborlane WV, Klingensmith G. Crisis in care: limited treatment options for type 2 diabetes in adolescents and youth. Diabetes Care. 2013;36:1777-1778. doi:10.2337/dc13-0743
-
- Constantino MI, Molyneaux L, Limacher-Gisler F, et al. Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care. 2013;36:3863-3869. doi:10.2337/dc12-2455
-
- Al-Saeed AH, Constantino MI, Molyneaux L, et al. An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes. Diabetes Care. 2016;39:823-829. doi:10.2337/dc15-0991
-
- TODAY Study Group. Long term complications in youth-onset type 2 diabetes. N Engl J Med. 2021;385:416-426. doi:10.1056/NEJMoa2100165
-
- TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366:2247-2256. doi:10.1056/nejmoa1109333
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical